Journal article · 2026 · Open access

Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia

Sandra Luza, Naimisha Talluri, Parsa Ravanfar, Darius Lane, Md. Jakaria, Adam Southon, Antonia H. Merritt, Chad Bousman, Ian Everall, Naveen Thomas, Mahesh Jayaram, Carlos Opazo and 2 more

Molecular Psychiatry · Published 2 November 2026 · DOI 10.1038/s41380-026-03855-2

Open PDFView at the publisherCite this paper

In brief

“Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia” is a 2026 journal article by Sandra Luza and 13 co-authors, published in Molecular Psychiatry. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY licence: the full text is free to read at Molecular Psychiatry.

Citations
0
References
120
Authors
14

Abstract

The molecular basis of schizophrenia is complex, involving an interplay of genetic and environmental factors. In recent postmortem and imaging studies, we identified disturbances in iron homeostasis in cortical and subcortical regions of individuals with schizophrenia. These may be relevant to neuropathology identified in the disorder and could relate to mechanisms of oxidative stress and inflammation. Recent work has proposed that there is a dysregulation of brain metals and other elements in schizophrenia that might impact on oxidative stress. Using a metallomics approach, we report robust changes in serum levels of pro-oxidant iron, anti-oxidant selenium, and the potassium-marker, rubidium, in a cohort of people with treatment-resistant schizophrenia (TRS). The cohort also expressed elevated levels of serum pro-inflammatory cytokines and hepcidin, and lower levels of anti-oxidant selenoproteins, selenoprotein-P1 (SEPP1) and glutathione peroxidase 3 (GPX3). The changes in serum iron, rubidium and selenium discriminate between control individuals and TRS cases, and they were not affected by age or clozapine serum levels. We propose that the changes in selenium and cytokines might drive the expression of hepcidin, resulting in reduced serum iron levels. Further research should investigate the relationship between peripheral and central measures of these elements and their metabolism, and further explore the relevance of pro-oxidant stress to the neuropathology of schizophrenia.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Luza, S., Talluri, N., Ravanfar, P., Lane, D., Jakaria, M., Southon, A., Merritt, A. H., Bousman, C., Everall, I., Thomas, N., Jayaram, M., Opazo, C., Bush, A. I., & Pantelis, C. (2026). Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia. Molecular Psychiatry. https://doi.org/10.1038/s41380-026-03855-2

MLA 9

Luza, Sandra, et al. “Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia.” Molecular Psychiatry, 2026. https://doi.org/10.1038/s41380-026-03855-2.

Chicago

Luza, Sandra, Naimisha Talluri, Parsa Ravanfar, Darius Lane, Md. Jakaria, Adam Southon, Antonia H. Merritt, et al. 2026. “Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia.” Molecular Psychiatry. https://doi.org/10.1038/s41380-026-03855-2.

Harvard

Luza, S. et al. (2026) ‘Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia’, Molecular Psychiatry. doi:10.1038/s41380-026-03855-2.

IEEE

S. Luza et al., “Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia,” Molecular Psychiatry, 2026, doi: 10.1038/s41380-026-03855-2.

BibTeX

@article{luza2026serum,
  title     = {{Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia}},
  author    = {Luza, Sandra and Talluri, Naimisha and Ravanfar, Parsa and Lane, Darius and Jakaria, Md. and Southon, Adam and Merritt, Antonia H. and Bousman, Chad and Everall, Ian and Thomas, Naveen and Jayaram, Mahesh and Opazo, Carlos and Bush, Ashley Ian and Pantelis, Christos},
  journal   = {Molecular Psychiatry},
  year      = {2026},
  doi       = {10.1038/s41380-026-03855-2},
  url       = {https://doi.org/10.1038/s41380-026-03855-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health

  • treatment-resistant schizophrenia
  • serum selenium
  • serum iron
  • rubidium
  • metallomics
  • iron homeostasis
  • oxidative stress
  • inflammatory cytokines

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Luza, S., Talluri, N., Ravanfar, P., Lane, D., Jakaria, M., Southon, A., Merritt, A. H., Bousman, C., Everall, I., Thomas, N., Jayaram, M., Opazo, C., Bush, A. I., & Pantelis, C. (2026). Serum selenium, iron and rubidium are altered in treatment-resistant schizophrenia. Molecular Psychiatry. https://doi.org/10.1038/s41380-026-03855-2

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecular Psychiatry: sign in and open the PDF from this page.

Who wrote this paper?

Sandra Luza, Naimisha Talluri, Parsa Ravanfar, Darius Lane, Md. Jakaria, Adam Southon, Antonia H. Merritt, Chad Bousman, Ian Everall, Naveen Thomas, Mahesh Jayaram, Carlos Opazo and 2 more.

What is the DOI of this paper?

10.1038/s41380-026-03855-2, permanently at https://doi.org/10.1038/s41380-026-03855-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.